
Breakthrough technologies are raising the ceiling for functional visual outcomes
Breakthrough technologies are raising the ceiling for functional visual outcomes
What to expect from 4 days in the Fortezza de Basso
The differential recruitment of the dorsal and ventral visual streams
Gauging patient perceptions in an ethnically diverse UK cohort
The Belgian B Corp company, founded in 2016, is partially owned by Rayner and distributed in over 20 European countries
The authors analysed severity and frequency of ocular pain among patients with DED living in altitudes above 2,500 meters during the COVID-19 pandemic
A higher body mass index was protective against glaucoma progression, while patients who were underweight had significantly faster rates of structural loss
The annual meeting held in Chicago, Illinois, featured new data and best practices for patient-centred care
OCU410ST is indicated for the treatment of ABCA4-associated retinopathies including Stargardt disease, retinitis pigmentosa and cone-rod dystrophy 3 (CORD3)
Uveitic relapses primarily manifest as anterior uveitis, the authors said
At the ESCRS meeting, Sir Harold Ridley’s legacy was put on display in a pop-up museum installation
ARVN001 is indicated for the treatment of uveitic macular oedema and certain other ophthalmic indications
The incidence was comparable to that of daily wear soft contact lenses
OPUVIZ, previously known as the biosimilar candidate SB15, has been approved for the treatment of nAMD, DME and other retinal diseases
The positive opinion marks a key regulatory step towards the approval of FYB203, which will go by the trade names AHZANTIVE and Baiama in the European Union
The CRL comes in response to a supplemental New Drug Application for Izervay, a treatment for geographic atrophy secondary to age-related macular degeneration
Optical coherence tomography will be in all eye care services by October 2025
Assessing two devices in a real-world setting
The biosimilar to reference aflibercept (Eylea, Bayer AG) is indicated to treat retinal diseases including neovascular age-related macular degeneration
A coalition of eye health advocacy groups vocalised support for the legislation
HG202, by HuidaGene Therapeutics, is formulated for clinical use in treating neovascular age-related macular degeneration
New analysis brings disease progression and therapeutics into focus
Following oculoplastic surgery, patients who underwent aromatherapy had shorter stays in the post-anesthesia care unit
Collaboration and outside-the-box thinking present significant opportunities for science and industry
This year’s Barcelona meeting brought together award-winning research data and leaders in the retina field
This article by Liem Trinh, MD highlights his experiences with the AT ELANA® 841P hydrophobic trifocal IOL and the ARTEVO® 750 and ARTEVO® 850 microscopes from ZEISS. Dr. Trinh discusses the benefits of the trifocal design of the AT ELANA 841P IOL and its ability to provide spectacle independence at all distances after cataract surgery. He also shares his positive experiences with the ARTEVO 850 microscope, which offers improved surgical visualization with RGB LED illumination and 3D viewing on a high dynamic range monitor. Additionally, Dr. Trinh discusses the potential benefits of integrated intraoperative optical coherence tomography (OCT) and the redesigned CALLISTO eye user interface.
Two glaucoma specialists discuss pairing patients with the right procedures
Caffeine has been shown to temporarily increase intraocular pressure and reduce blood flow in critical ocular regions
Investigators from Bergen, Norway, and Cleveland, Ohio, collaborated on the predictive model
Patients underwent electropuncture, low-intensity laser stimulation of the ciliary muscle, combined therapy and optical-reflex treatment of accommodation